Australia’s active vaccine safety system

AusVaxSafety will begin routine safety monitoring of the 2026 seasonal influenza vaccines for all age groups as soon as the vaccines become available in Australia.

2026 influenza vaccines used in Australia

Standard inactivated (injectable) influenza vaccines

  • Flucelvax (individuals aged 6 months and older)
  • Fluzone (individuals aged 6 months and older)
  • Influvac (individuals aged 6 months and older)
  • Vaxigrip (individuals aged 6 months and older)

Adjuvanted or high-dose inactivated (injectable) influenza vaccines 

  • Fluad (individuals aged 50 years and older)
  • Fluzone High-Dose (individuals aged 60 years and over)

Intranasal live attenuated (nasal spray) influenza vaccine 

  • FluMist (individuals aged 2 years to less than 18 years)

Statement on the Administration of Seasonal Influenza Vaccines in 2026 – Australian Technical Advisory Group on Immunisation
Influenza vaccines frequently asked questions – National Centre for Immunisation Research and Surveillance

How AusVaxSafety monitors influenza vaccine safety

AusVaxSafety collects vaccine safety data using vaccine safety surveys sent to influenza vaccine recipients in the days following their vaccination. Once monitoring begins, safety data for the 2026 influenza vaccines will be updated monthly throughout the influenza season. 

Previous influenza vaccine safety data

AusVaxSafety influenza vaccine safety data from the 2025 influenza season are available below.
 


Latest influenza vaccine safety data

Click on the tiles below to view 2025 AusVaxSafety influenza vaccine safety data for specific age and population groups.